The absolute requirement for the 85 kDa cytosolic phospholipase A2 (cPLA2) in the PMA stimulation of proton efflux through the NADPH-oxidase-associated proton channel, has previously been demonstrated using a PLB-985 cell line deficient in cPLA2 (PLB-D). The flux of protons in Chinese-Hamster ovary (CHO) cells that express the N-terminal 230-amino-acid (NT) fragment of gp91phox is activated by arachidonic acid (AA) added externally. To investigate the physiological role of cPLA2, and the intracellular AA that it releases, in the activation of proton flux through the NT fragment of gp91phox, this fragment was stably expressed in PLB-985 cells (PLB-985 NT) and in PLB-D cells (PLB-D NT). The expression of the NT fragment of gp91phox by itself in PLB-985 did not initiate differentiation and did not alter their ability to undergo differentiation after the addition of DMSO. Addition of PMA induced a proton efflux from undifferentiated PLB-985 NT cells expressing the NT fragment of gp91phox, which was inhibited by zinc. In contrast, PMA failed to activate proton efflux in undifferentiated PLB-D NT cells, lacking the expression of cPLA2; however, addition of AA restored the efflux of protons in these cells. These results establish an essential and specific physiological requirement of cPLA2-generated AA in the activation of proton flux through the NT fragment of gp91phox.
Skip Nav Destination
Article navigation
September 2003
- PDF Icon PDF LinkFront Matter
Research Article|
September 01 2003
The requirement of cytosolic phospholipase A2 for the PMA activation of proton efflux through the N-terminal 230-amino-acid fragment of gp91phox
Tosti J. MANKELOW;
Tosti J. MANKELOW
1
∗Department of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, U.K.
Search for other works by this author on:
Etai PESSACH;
Etai PESSACH
†Laboratory of Infectious Diseases, Department of Clinical Biochemistry, Faculty of Health Sciences, Soroka Medical Center and Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
Search for other works by this author on:
Rachel LEVY;
Rachel LEVY
†Laboratory of Infectious Diseases, Department of Clinical Biochemistry, Faculty of Health Sciences, Soroka Medical Center and Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
Search for other works by this author on:
Lydia M. HENDERSON
Lydia M. HENDERSON
2
∗Department of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, U.K.
2To whom correspondence should be addressed (e-mail L.M.Henderson@bris.ac.uk).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
April 02 2003
Revision Received:
May 19 2003
Accepted:
May 23 2003
Accepted Manuscript online:
May 23 2003
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2003
2003
Biochem J (2003) 374 (2): 315–319.
Article history
Received:
April 02 2003
Revision Received:
May 19 2003
Accepted:
May 23 2003
Accepted Manuscript online:
May 23 2003
Citation
Tosti J. MANKELOW, Etai PESSACH, Rachel LEVY, Lydia M. HENDERSON; The requirement of cytosolic phospholipase A2 for the PMA activation of proton efflux through the N-terminal 230-amino-acid fragment of gp91phox. Biochem J 1 September 2003; 374 (2): 315–319. doi: https://doi.org/10.1042/bj20030495
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.